Skip to main content About News Giving All Departments Contact Us Site Map
 University of Texas Southwestern Medical School
 
Search       
Print Friendly  
spacer Home Education Research Patient Care Faculty & Administration Resource Careers
Faculty Directory Administration Administrative Departments
border=0
| Home > Faculty & Administration >
Scott Cameron

 
 
Faculty Directory
 
 
Find a Doctor
 
 
Faculty Research Interests
 
 
Search Help
 
 
Update Faculty ProfileAccessible on campus or vpn
 
 
 

Scott Cameron, M.D., Ph.D.

 Details of Research

Biographical Sketch Details of Research Personal Overview How to Contact
Scott Cameron
Name:
  Scott Cameron, M.D., Ph.D.
Academic Title:
  Assistant Professor
Primary Appointment:
  Pediatrics
Secondary Appointment:
  Molecular Biology
School:
  Graduate School of Biomedical Sciences
Southwestern Medical School
Degree Program:
  Genetics and Development
Affiliations:
  Children's - Hematology-Oncology
Department Website:
  Pediatric Hematology-Oncology
Lab Website:
  Scott Cameron Lab
Email:
  Scott Cameron, M.D., Ph.D.
Physician Profile:
  Scott Cameron, M.D., Ph.D.

 RESEARCH OVERVIEW
 
Developmental biology is defined by the attempt to understand how different cell fates are established in a multicellular organism. Mutations in this process contribute to disease in people. Caenorhabditis elegans offers extraordinarily powerful tools for the identification and analysis of pathways that regulate cell fates, including sophisticated genetics and a known, invariant cell lineage (i.e. the ancestry and fate of every cell is known from the zygote to the adult in a wild type animal, and is the same in essentially every animal). Knowledge of the invariant cell lineage makes it possible to identify and study mutations affecting cell fates at the level of individual cells. My laboratory focuses on how the pattern of cell fates, and particularly of programmed cell deaths, is determined in one tissue of C. elegans, the ventral nerve cord. We have used a combination of genetic screens (both conventional and RNAi-based) and molecular biology to identify genes that regulate the pattern of programmed cell deaths and cell fates in the ventral nerve cord. We are beginning to work out the molecular mechanisms through which these genes act during development of the ventral nerve cord. It is our goal to elucidate the genetic pathways and molecular mechanisms that regulate cell death in C. elegans, and to test whether the mammalian counterparts of these pathways function similarly during the development of cancer.

We have recently shown that mutations in two classical regulators of developmental fates result in an abnormal pattern of cell death in the ventral cord, and that these genes, which encode transcription factors, directly regulate genes in the canonical cell death pathway to determine whether individual cells survive or die. These results support the perhaps surprising hypothesis that ’master regulators’ of cell fates also act as ’micromanagers’ to determine whether individual cells survive or die.

The human counterparts of these genes are mutant in children with leukemia, suggesting that mutations in these genes contribute to leukemogenesis by preventing programmed cell death of lymphoblasts. Indeed, the human counterparts of all three pathways now known to regulate programmed cell death in C. elegans are mutant in cancer, suggesting that analysis of programmed cell death in C. elegans will suggest the mechanisms whereby some mutations contribute to the development of cancer. In the one case that has been investigated, the genetic pathway that prevents programmed cell death in C. elegans is required to prevent apoptosis of the cancerous cells, confirming the value of our approach. We are currently extending our understanding of the regulation of programmed cell death in the ventral nerve cord of C. elegans and beginning our efforts to extend our findings into human cancer cells.
 
 RESEARCH INTERESTS
 
Developmental regulation of programed cell death and cell lineage
Leukemogenesis and hematopoietic cell lineage
 
 RECENT PUBLICATIONS
 
Reddien PW, Cameron S and Horvitz HR, "Phagocytosis promotes programmed cell death in C. elegans" Nature, 412:198-202, 2001
Hock H, Hamblen MJ, Rooke HM, Traver D, Bronson RT, Cameron S and Orkin SH, "The zinc finger transcription factor Gfi-1 is required for neutrophil differentiation and refines the identity of the myeloid lineages" Immunity, 18:109-120, 2003
Saleque S, Cameron S and Orkin SH, "The zinc-finger protooncogene Gfi-1b is essential for development of the erythroid and megakarycoytic lineages" Genes and Development, 16:301-306, 2001
McLaughlin M, Robson CD, Kieran MW, Jacks T, Pomeroy SL and Cameron S, "Marked regression of metastatic pilocytic astrocytoma during treatment with imatinib mesylate (STI-571, Gleevec): A case report and laboratory investigation" J Pedi Hem Oncol, 25:644-648, August 2003
Cameron S, Clark S, McDermott JB, Aamodt E and Horvitz HR, "PAG-3, a Zn finger transcription factor, determines neuroblast fate in C. elegans" Development, 129:1763-1774, 2002
 
 SIGNIFICANT PUBLICATIONS
 
Cameron S, Clark S, McDermott JB, Aamodt E and Horvitz HR, "PAG-3, a Zn finger transcription factor, determines neuroblast fate in C. elegans" Development, 129:1763-1774, 2002
Saleque S, Cameron S and Orkin SH, "The zinc-finger protooncogene Gfi-1b is essential for development of the erythroid and megakaryocytic lineages" Genes and Development, 16:301-306, 2001
Hock H, Hamblen MJ, Rooke HM, Traver D, Bronson RT, Cameron S and Orkin SH, "The zinc finger transcription factor Gfi-1 is required for neutrophil differentiation and refines the identity of the myeloid lineages" Immunity, 18:109-120, 2003
Reddien PW, Cameron S and Horvitz HR, "Phagocytosis promotes programmed cell death in C. elegans" Nature, 412:198-202, 2001
 
Point and right click (click and hold for Mac users) your mouse on and select "Save this link (or target) as..." option to save the file to your local computer.